Christopher Stone
2014
In 2014, Christopher Stone earned a total compensation of $1.7M as Vice President, General Counsel and Secretary at PDL BioPharma, a 30% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,059,315 |
|---|---|
| Salary | $415,760 |
| Stock Awards | $252,300 |
| Other | $10,000 |
| Total | $1,737,375 |
Stone received $1.1M in non-equity incentive plan, accounting for 61% of the total pay in 2014.
Stone also received $415.8K in salary, $252.3K in stock awards and $10K in other compensation.
Rankings
In 2014, Christopher Stone's compensation ranked 5,126th out of 13,032 executives tracked by ExecPay. In other words, Stone earned more than 60.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,126 out of 13,032 | 61st |
Division Manufacturing | 1,833 out of 4,966 | 63rd |
Major group Chemicals And Allied Products | 606 out of 1,686 | 64th |
Industry group Drugs | 462 out of 1,365 | 66th |
Industry Biological Products, Except Diagnostic Substances | 77 out of 236 | 67th |
Source: SEC filing on April 28, 2017.
Stone's colleagues
We found four more compensation records of executives who worked with Christopher Stone at PDL BioPharma in 2014.